FI894423A0 - Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer. - Google Patents

Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer.

Info

Publication number
FI894423A0
FI894423A0 FI894423A FI894423A FI894423A0 FI 894423 A0 FI894423 A0 FI 894423A0 FI 894423 A FI894423 A FI 894423A FI 894423 A FI894423 A FI 894423A FI 894423 A0 FI894423 A0 FI 894423A0
Authority
FI
Finland
Prior art keywords
foerhindring
broestcancer
befruktning
kontroll
faring
Prior art date
Application number
FI894423A
Other languages
English (en)
Finnish (fi)
Other versions
FI894423A7 (fi
FI894423L (fi
Inventor
Michael Cohen
Original Assignee
Applied Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Med Res filed Critical Applied Med Res
Publication of FI894423A7 publication Critical patent/FI894423A7/fi
Publication of FI894423L publication Critical patent/FI894423L/fi
Publication of FI894423A0 publication Critical patent/FI894423A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
FI894423A 1987-03-23 1988-03-22 Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer. FI894423A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/029,229 US4855305A (en) 1987-03-23 1987-03-23 Compositions and methods of effecting contraception utilizing melatonin
PCT/US1988/000971 WO1988007370A1 (en) 1987-03-23 1988-03-22 Compositions and methods of effecting contraception and control of breast cancer

Publications (3)

Publication Number Publication Date
FI894423A7 FI894423A7 (fi) 1989-09-19
FI894423L FI894423L (fi) 1989-09-19
FI894423A0 true FI894423A0 (fi) 1989-09-19

Family

ID=21847942

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894423A FI894423A0 (fi) 1987-03-23 1988-03-22 Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer.

Country Status (26)

Country Link
US (1) US4855305A (cs)
EP (1) EP0354921B1 (cs)
JP (2) JP2965160B2 (cs)
KR (1) KR890700349A (cs)
CN (1) CN1041383C (cs)
AT (1) ATE143807T1 (cs)
AU (3) AU628784B2 (cs)
BG (1) BG51075A1 (cs)
BR (1) BR8807426A (cs)
CA (1) CA1322527C (cs)
DD (1) DD269557A5 (cs)
DE (1) DE3855606T2 (cs)
EG (1) EG18583A (cs)
ES (1) ES2009251A6 (cs)
FI (1) FI894423A0 (cs)
GR (1) GR1002146B (cs)
HU (1) HU208487B (cs)
IL (1) IL85814A (cs)
IN (1) IN166946B (cs)
NZ (1) NZ223989A (cs)
OA (1) OA09134A (cs)
PH (1) PH26709A (cs)
PT (1) PT87053B (cs)
RU (1) RU2114621C1 (cs)
WO (1) WO1988007370A1 (cs)
ZA (1) ZA882079B (cs)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001395B (el) * 1987-03-23 1993-10-29 Michael Cohen Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
EP0300630A3 (en) * 1987-07-03 1990-03-28 Schering Agrochemicals Limited Melatonin for regulating animal reproduction
IL87574A0 (en) * 1987-08-28 1989-01-31 Regulin Ltd Composition for regulating animal reproduction containing an indole derivative
GR900100024A (el) * 1989-01-17 1991-06-07 Amr Int Μέθοδος θεραπείας του προεμμηνορροϊκού συνδρόμου.
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
IN170311B (cs) * 1989-01-17 1992-03-14 Cohen Michael
NZ233697A (en) * 1989-05-17 1996-12-20 Applied Med Res Ltd Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
AU644367B2 (en) * 1989-05-17 1993-12-09 Applied Medical Research Ltd Use of melatonin derivatives for effecting contraception
IT1243193B (it) * 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
ES2082959T3 (es) * 1990-09-28 1996-04-01 I F L O S A S Di Giorgio E Ald Procedimiento para desarrollar la sintesis de una droga contraceptiva y de control del ciclo menstrual que tiene propiedades anticinetosicas, oncostaticas y terapeuticas para el tratamiento de los tumores de mama y melanomas.
EP0518468B1 (en) * 1991-05-09 1999-06-30 Neurim Pharmaceuticals (1991) Limited Melatonin containing compositions
PT100973A (pt) * 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IL105240A (en) * 1992-04-07 1999-04-11 Neurim Pharma 1991 The use of melatonin in the preparation of a drug for the treatment of benign prostatic hyperplasia
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6620836B1 (en) * 1997-01-22 2003-09-16 Jay Patrick Antiarrhythmic and tranquilizer composition and treatment
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
AU747710B2 (en) 1997-11-14 2002-05-23 Akzo Nobel N.V. Progestogen-antiprogestogen regimens
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
PL205279B1 (pl) * 2000-08-30 2010-03-31 Besins International Lab Zastosowanie żelu hydroalkoholowego zawierającego testosteron i zestaw do leczenia zaburzenia erekcji
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
WO2003077900A1 (en) * 2002-03-14 2003-09-25 Prevention, L.L.C. A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
RU2313339C2 (ru) 2003-09-09 2007-12-27 Фумафарм Аг Применение производных фумаровой кислоты для лечения сердечной недостаточности и астмы
CN1972692A (zh) * 2004-05-26 2007-05-30 惠氏公司 治疗经前焦虑障碍的组合物和方法
HUE028342T2 (en) 2004-10-08 2016-12-28 Forward Pharma As Pharmaceutical preparations containing controlled release fumaric acid ester
EP3456329B1 (en) 2005-10-12 2024-12-04 Besins Healthcare Luxembourg SARL Improved testosterone gel and method of use
CN101516255A (zh) * 2006-09-13 2009-08-26 皇家飞利浦电子股份有限公司 用于自动调整褪黑素的剂量和/或递送褪黑素的装置
DE13156663T1 (de) 2007-02-08 2022-07-14 Biogen Ma Inc. NRF2-Screening-Assays sowie entsprechende Verfahren und Zusammensetzungen
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
EP3124023B1 (en) * 2014-03-27 2023-08-30 Servicio Andaluz De Salud Durable preparation of an injectable of melatonin exhibiting long-term stability
RU2617518C2 (ru) * 2015-07-01 2017-04-25 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения и контрацепции самок млекопитающих
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
JPH0778007B2 (ja) * 1985-03-04 1995-08-23 セレ−ナ （セル・エンジニアリング） ア−・ゲ− メラトニン組成物とその使用
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors

Also Published As

Publication number Publication date
AU8693891A (en) 1991-12-19
CN1041383C (zh) 1998-12-30
BR8807426A (pt) 1990-04-10
AU1683088A (en) 1988-11-02
GR1002146B (en) 1996-02-19
IN166946B (cs) 1990-08-11
JPH02502724A (ja) 1990-08-30
DD269557A5 (de) 1989-07-05
HU208487B (en) 1993-11-29
OA09134A (en) 1991-10-31
EP0354921A4 (en) 1991-08-07
EG18583A (en) 1993-06-30
US4855305A (en) 1989-08-08
FI894423A7 (fi) 1989-09-19
FI894423L (fi) 1989-09-19
AU5513494A (en) 1994-04-14
DE3855606D1 (de) 1996-11-14
ZA882079B (en) 1988-09-15
BG51075A1 (en) 1993-02-15
PT87053A (pt) 1989-03-30
DE3855606T2 (de) 1997-02-13
EP0354921A1 (en) 1990-02-21
PH26709A (en) 1992-09-15
IL85814A0 (en) 1990-02-09
IL85814A (en) 1992-05-25
WO1988007370A1 (en) 1988-10-06
HUT52954A (en) 1990-09-28
KR890700349A (ko) 1989-04-24
ATE143807T1 (de) 1996-10-15
AU628784B2 (en) 1992-09-24
EP0354921B1 (en) 1996-10-09
NZ223989A (en) 1991-08-27
RU2114621C1 (ru) 1998-07-10
PT87053B (pt) 1993-09-30
GR880100177A (el) 1989-01-31
ES2009251A6 (es) 1989-09-16
AU676523B2 (en) 1997-03-13
JP2965160B2 (ja) 1999-10-18
CA1322527C (en) 1993-09-28
CN88101379A (zh) 1988-10-05
JPH1171276A (ja) 1999-03-16

Similar Documents

Publication Publication Date Title
FI894423A0 (fi) Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer.
PL323729A1 (en) Skin sticking plaster and method of administering sole 17-deacetyl norgestimate or together with estrogen
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
ZA913282B (en) Dosage form
LTIP1751A (en) Oral composition for the treatment of inflammatory bowel diseases
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
ES481109A1 (es) Un metodo de preparacion de un extracto de stephania cepha- rantha.
CA2056364A1 (en) Compositions and methods of effecting contraception
BE894860A (fr) Therapeutique adjuvante par agent progestatif
GR900100369A (en) Contraception compositions and methods
RO89569A (ro) Procedeu si instalatie pentru confectionarea tampoanelor higienice pentru femei
KR900017599A (ko) 종양 치료용 약학 조성물
Qi et al. Hemodynamic assessment of intravenous Isosorbidi Dinitras in coronary heart disease
IT1243978B (it) Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva, nei tumori del seno, dell'utero e nel melanoma.
Shimada et al. Clinical studies on serum lipids in the patients with tumor of the prostate gland. 3rd report: changes of serum lipid peroxide levels during estrogen therapy for prostatic cancer and therapeutic and preventive effect of riboflavin tetrabutylate for hyperlipidemia
MX9604426A (es) Reduccion de irritacion de la piel durante el surtido por electrotransporte.
IT1236834B (it) Complessi del 4-idrossi-2-metil-n--2-piridinil-2-h,2-benzotiazina-3- carbossiammide-1,1-diossido con cilodestrine, aventi azione anti- infiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili
NZ516564A (en) Cancer therapy

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: APPLIED MEDICAL RESEARCH, LTD.